DE69700317T2 - Mikrotröpfchen-Arzneizubereitungen enthaltend Propofol - Google Patents

Mikrotröpfchen-Arzneizubereitungen enthaltend Propofol

Info

Publication number
DE69700317T2
DE69700317T2 DE69700317T DE69700317T DE69700317T2 DE 69700317 T2 DE69700317 T2 DE 69700317T2 DE 69700317 T DE69700317 T DE 69700317T DE 69700317 T DE69700317 T DE 69700317T DE 69700317 T2 DE69700317 T2 DE 69700317T2
Authority
DE
Germany
Prior art keywords
propofol
microdroplet
pharmaceutical preparations
preparations containing
pml
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69700317T
Other languages
English (en)
Other versions
DE69700317D1 (de
Inventor
Duncan Haynes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RTP Pharma Corp
Original Assignee
Research Triangle Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24469788&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69700317(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Research Triangle Pharmaceuticals Ltd filed Critical Research Triangle Pharmaceuticals Ltd
Application granted granted Critical
Publication of DE69700317D1 publication Critical patent/DE69700317D1/de
Publication of DE69700317T2 publication Critical patent/DE69700317T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Motorcycle And Bicycle Frame (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fats And Perfumes (AREA)
DE69700317T 1996-03-19 1997-03-19 Mikrotröpfchen-Arzneizubereitungen enthaltend Propofol Expired - Lifetime DE69700317T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/616,511 US5637625A (en) 1996-03-19 1996-03-19 Propofol microdroplet formulations

Publications (2)

Publication Number Publication Date
DE69700317D1 DE69700317D1 (de) 1999-08-19
DE69700317T2 true DE69700317T2 (de) 1999-12-02

Family

ID=24469788

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69700317T Expired - Lifetime DE69700317T2 (de) 1996-03-19 1997-03-19 Mikrotröpfchen-Arzneizubereitungen enthaltend Propofol

Country Status (19)

Country Link
US (1) US5637625A (de)
EP (1) EP0796616B1 (de)
JP (1) JP2000507244A (de)
KR (1) KR100484516B1 (de)
CN (1) CN1124845C (de)
AT (1) ATE182074T1 (de)
AU (1) AU719756B2 (de)
BR (1) BR9708099B8 (de)
CA (1) CA2249375C (de)
DE (1) DE69700317T2 (de)
DK (1) DK0796616T3 (de)
ES (1) ES2135969T3 (de)
FI (1) FI982009A (de)
GR (1) GR3031414T3 (de)
HU (1) HU225046B1 (de)
NO (1) NO324498B1 (de)
NZ (1) NZ331669A (de)
RU (1) RU2186564C2 (de)
WO (1) WO1997034588A1 (de)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070116761A1 (en) * 1993-02-22 2007-05-24 Desai Neil P Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
US6749868B1 (en) 1993-02-22 2004-06-15 American Bioscience, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
DE69637441T2 (de) * 1995-10-17 2009-03-05 Jagotec Ag Verabreichung unlöslicher arzneistoffe
US6465016B2 (en) * 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
US7255877B2 (en) * 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
CH692322A5 (it) * 1997-05-26 2002-05-15 Westy Ag Formulazione iniettabile limpida di Propofol.
BRPI9810945B8 (pt) * 1997-06-27 2021-05-25 Abraxis Bioscience Inc formulações de agentes farmacológicos, métodos para sua preparação e métodos para uso das mesmas
US6638621B2 (en) * 2000-08-16 2003-10-28 Lyotropic Therapeutics, Inc. Coated particles, methods of making and using
CO4810371A1 (es) 1998-02-10 1999-06-30 Gensia Sicor Inc Composicion de propofol que contiene sulfito
CN1289091C (zh) * 1998-02-11 2006-12-13 Rtp药品公司 治疗炎症的药物组合物和相关用途
US6254853B1 (en) * 1998-05-08 2001-07-03 Vyrex Corporation Water soluble pro-drugs of propofol
CN1245955C (zh) 1998-05-29 2006-03-22 斯凯伊药品加拿大公司 热保护微粒组合物及其最终蒸汽灭菌的方法
US6204257B1 (en) 1998-08-07 2001-03-20 Universtiy Of Kansas Water soluble prodrugs of hindered alcohols
IL141095A0 (en) * 1998-08-19 2002-02-10 Rtp Pharma Inc Injectable aqueous dispersions of propofol
US6150423A (en) 1998-10-15 2000-11-21 Phoenix Scientific, Inc. Propofol-based anesthetic and method of making same
US6140374A (en) * 1998-10-23 2000-10-31 Abbott Laboratories Propofol composition
JP4809533B2 (ja) 1998-11-20 2011-11-09 オバン・エナジー・リミテッド 分散し得るリン脂質で安定化されたミクロ粒子
CN1151782C (zh) * 1999-01-28 2004-06-02 迪内希·尚蒂拉尔·帕特尔 一种具有哺乳动物麻醉的诱导和保持以及镇静用途的药用注射液
US6177477B1 (en) * 1999-03-24 2001-01-23 American Home Products Corporation Propofol formulation containing TRIS
US6100302A (en) * 1999-04-05 2000-08-08 Baxter International Inc. Propofol formulation with enhanced microbial characteristics
GB2350297A (en) * 1999-05-27 2000-11-29 Abbott Lab Injectable halogenated anesthetic formulation in emulsion form
KR100801588B1 (ko) * 1999-09-21 2008-02-05 스키에파마 캐나다 인코포레이티드 생물학적 유효 물질의 표면 변형된 미립자 조성물
US6071933A (en) * 1999-12-03 2000-06-06 Diversified Medical Innovations, Inc. Homogeneous remifentanil-propofol blend for patient controlled anesthesia and process for its use
GB2359747B (en) * 2000-02-29 2002-04-24 Maelor Pharmaceuticals Ltd Anaesthetic formulations
AU2001257115B2 (en) 2000-04-20 2005-01-27 Rtp Pharma Inc. Improved water-insoluble drug particle process
CN1460019A (zh) 2000-06-16 2003-12-03 斯凯伊药品加拿大公司 改进的可注射的普鲁普酚分散剂
US6623765B1 (en) * 2000-08-01 2003-09-23 University Of Florida, Research Foundation, Incorporated Microemulsion and micelle systems for solubilizing drugs
JP4969761B2 (ja) 2000-08-31 2012-07-04 オバン・エナジー・リミテッド 所望粒度を持つ固体基材の小粒子および第一材料の小粒状物を含む相乗作用性混合物を製造する方法
JP2004509146A (ja) * 2000-09-20 2004-03-25 スカイファーマ・カナダ・インコーポレーテッド 安定化フィブレート微粒子
US8586094B2 (en) 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
EP1361867B1 (de) * 2001-02-22 2007-03-21 Jagotec AG Fibrat-statin kombinationen mit verminderten von der nahrungsaufnahme abhängigen auswirkungen
US6991809B2 (en) 2001-06-23 2006-01-31 Lyotropic Therapeutics, Inc. Particles with improved solubilization capacity
US20030054042A1 (en) * 2001-09-14 2003-03-20 Elaine Liversidge Stabilization of chemical compounds using nanoparticulate formulations
US6815555B2 (en) 2001-09-26 2004-11-09 Theravance, Inc. Substituted phenol compounds useful for anesthesia and sedation
MXPA04002446A (es) * 2001-09-26 2004-07-23 Baxter Int Preparacion de nanoparticulas de tamano de submicras mediante dispersion y remocion de la fase liquida o solvente.
US7112340B2 (en) * 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
KR20040080444A (ko) * 2001-12-28 2004-09-18 길포드 파마슈티컬스 인코포레이티드 수용성인 프로포폴 전구약물의 약학적 수성 제제
JP4842514B2 (ja) * 2002-03-20 2011-12-21 エラン ファーマ インターナショナル，リミティド 血管新生抑制剤のナノ粒子組成物
US20080220075A1 (en) * 2002-03-20 2008-09-11 Elan Pharma International Ltd. Nanoparticulate compositions of angiogenesis inhibitors
HUP0600241A2 (en) * 2002-04-08 2006-07-28 Mgi Gp Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same
BR0313060A (pt) * 2002-07-29 2005-06-28 Transform Pharmaceuticals Inc Composições farmacêuticas aquosas de 2,6-diisopropilfenol
US7550155B2 (en) * 2002-07-29 2009-06-23 Transform Pharmaceuticals Inc. Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
US20040220283A1 (en) * 2002-07-29 2004-11-04 Transform Pharmaceuticals, Inc. Aqueous 2,6-diisopropylphenol pharmaceutical compositions
CA2503956A1 (en) * 2002-10-29 2004-05-13 Transform Pharmaceuticals, Inc. Propofol with cysteine
US20060134145A1 (en) * 2002-12-06 2006-06-22 Otsuka Pharmaceutical Factory, Inc. Propofol-containing fat emulsions
US20040225022A1 (en) * 2003-05-09 2004-11-11 Desai Neil P. Propofol formulation containing reduced oil and surfactants
US8476010B2 (en) 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
US7182948B2 (en) * 2003-08-04 2007-02-27 Ko Manufacturing, Inc. Topical veterinary compositions and methods for the treatment and prevention of infection
WO2005070465A2 (en) * 2004-01-14 2005-08-04 Gilead Sciences, Inc. Lipid-based dispersions useful for drug delivery
US7125954B2 (en) 2005-01-27 2006-10-24 General Electric Company Method for producing polyether polymers
MX2007015183A (es) * 2005-06-14 2008-02-19 Baxter Int Formulaciones farmaceuticas para minimizar las interacciones farmaco-farmaco.
ES2719093T3 (es) * 2005-08-31 2019-07-08 Abraxis Bioscience Llc Composiciones de fármacos poco solubles en agua con mayor estabilidad y métodos para su preparación
BRPI0615265A8 (pt) * 2005-08-31 2018-03-06 Abraxis Bioscience Llc composições compreendendo agentes farmacêuticos pouco hidrossoluíveis e agentes antimicrobianos
BRPI0618661A2 (pt) * 2005-11-15 2011-09-06 Baxter Int composições de inibidores de lipoxigenase
US8426467B2 (en) 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US8722736B2 (en) * 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
RU2535001C1 (ru) * 2013-07-11 2014-12-10 Общество с ограниченной ответственностью "ВИК-здоровье животных" Микроколлоидный раствор пропофола для анестезии
EP3302433A4 (de) * 2015-06-01 2019-01-23 Autotelic LLC Phospholipid-beschichtete therapeutische nanopartikel und zugehörige verfahren
US20160346221A1 (en) 2015-06-01 2016-12-01 Autotelic Llc Phospholipid-coated therapeutic agent nanoparticles and related methods
WO2017218630A2 (en) * 2016-06-15 2017-12-21 Autotelic Llc Phospholipid-coated therapeutic agent nanoparticles and related methods
MX2022007691A (es) * 2019-12-20 2022-07-19 Fresenius Kabi Austria Gmbh Metodo para producir emulsiones aceite en agua.
EP4056038A1 (de) * 2021-03-10 2022-09-14 Basf Se Wirkstoffhaltige mikrokapseln

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4798846A (en) * 1974-03-28 1989-01-17 Imperial Chemical Industries Plc Pharmaceutical compositions
GB1472793A (en) * 1974-03-28 1977-05-04 Ici Ltd Pharmaceutical compositions
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
US4725442A (en) * 1983-06-17 1988-02-16 Haynes Duncan H Microdroplets of water-insoluble drugs and injectable formulations containing same
DE4132677C2 (de) * 1991-10-01 1995-08-24 Braun Melsungen Ag Flüchtige Inhalationsnarkotika enthaltende Liposomen, ihre Herstellung und Verwendung
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
US5496537A (en) * 1995-03-23 1996-03-05 Henry; Richard A. Propofol hydrofluorocarbon propellant formulations

Also Published As

Publication number Publication date
CN1218398A (zh) 1999-06-02
BR9708099B8 (pt) 2014-04-29
FI982009A0 (fi) 1998-09-17
BR9708099A (pt) 2000-01-04
KR20000064762A (ko) 2000-11-06
GR3031414T3 (en) 2000-01-31
AU719756B2 (en) 2000-05-18
CA2249375C (en) 2002-06-18
NO984370L (no) 1998-09-18
RU2186564C2 (ru) 2002-08-10
HUP9902553A2 (hu) 2000-10-28
DE69700317D1 (de) 1999-08-19
KR100484516B1 (ko) 2005-09-02
WO1997034588A1 (en) 1997-09-25
BR9708099B1 (pt) 2010-02-23
EP0796616B1 (de) 1999-07-14
CN1124845C (zh) 2003-10-22
AU2329297A (en) 1997-10-10
ATE182074T1 (de) 1999-07-15
JP2000507244A (ja) 2000-06-13
DK0796616T3 (da) 1999-11-29
ES2135969T3 (es) 1999-11-01
NZ331669A (en) 2000-01-28
HU225046B1 (hu) 2006-05-29
HUP9902553A3 (en) 2001-04-28
NO984370D0 (no) 1998-09-18
NO324498B1 (no) 2007-10-29
FI982009A (fi) 1998-09-17
CA2249375A1 (en) 1997-09-25
EP0796616A1 (de) 1997-09-24
US5637625A (en) 1997-06-10

Similar Documents

Publication Publication Date Title
DE69700317T2 (de) Mikrotröpfchen-Arzneizubereitungen enthaltend Propofol
CA2207218A1 (en) Controlled release composition forming a reversed micellar (l2) structure or a normal micellar (l1) structure
RU98118914A (ru) Изготовление лекарственных средств из микрокапель пропофола
WO1996028131A3 (de) Kosmetische oder pharmazeutische mikroemulsionen
Krieger et al. Replacement of neutral lipids of low density lipoprotein with esters of long chain unsaturated fatty acids
CA2146757A1 (en) Stabilization of fluorocarbon emulsions
KR100414853B1 (de)
CA2206602A1 (en) Sequential delivery of purified biological and chemical reagents
CA2067754A1 (en) Preparation for the application of agents in mini-droplets
CA2039491A1 (en) Stable compositions for parenteral administration and method of making same
DE69327100T2 (de) Gemisch mit hohem gehalt an cis beta-carotin
KR950002747A (ko) 사이클로스포린 연질캅셀제 조성물
KR910005760A (ko) 살충제 및/또는 살비제 조성물
CA2155763A1 (en) Cosmetic compositions
MXPA97007996A (es) Preparado para el transporte de sustancias activas a traves de barreras.
MX9500133A (es) Emulsiones de agua/aceite de alta fase interna.
EP0392127A3 (de) Ökologisches Schädlingsbekämpfungsmittel, das die Umwelt nicht verschmutzt, dessen Herstellung und Verwendung zum Bekämpfen von Schädlingen an Pflanzen
KR970014571A (ko) 1,2-디브로모-2,4-디시아노부탄과 파라하이드록시벤조산 에스테르와의 상승작용성 항미생물성 조성물
Talsma et al. Multilamellar or multivesicular vesicles?
CA2220178A1 (en) Dry preparations containing microbially produced oil
KR900001370A (ko) 이부딜라스트 지질 미세구 및 그의 제조방법
RU94044961A (ru) Способ получения масла из семян амаранта
TH6112A (th) สารกำจัศัตรูพืช
KR840008686A (ko) 맥아음료의 광안정성을 조절하는 방법
RU96103594A (ru) Аэрозольное дезинфицирующее средство "вилаг-2"

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: RTP PHARMA CORP., DURHAM, N.C., US